3232 FDA's Approach to Science, Policy, and Research Needs for Nanotechnology

Saturday, February 19, 2011: 2:30 PM
207B (Washington Convention Center )
Carlos Peņa , U.S. Food and Drug Administration, Bethesda, MD
The speaker will discuss the role of the FDA Nanotechnology Task Force, composed of key officials across the agency, in establishing and enhancing partnerships with national and international regulatory agencies as well as other stakeholders focused on nanotechnology.